These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Present experiences with omeprazole in the Zollinger-Ellison syndrome. Lamers CB Scand J Gastroenterol Suppl; 1986; 118():123-8. PubMed ID: 3460167 [TBL] [Abstract][Full Text] [Related]
29. Omeprazole in Zollinger-Ellison syndrome. Effects of a single dose and of long-term treatment in patients resistant to histamine H2-receptor antagonists. Lambers CB; Lind T; Moberg S; Jansen JB; Olbe L N Engl J Med; 1984 Mar; 310(12):758-61. PubMed ID: 6142418 [TBL] [Abstract][Full Text] [Related]
30. Optimal treatment of Zollinger-Ellison syndrome and related conditions in elderly patients. Tomassetti P; Salomone T; Migliori M; Campana D; Corinaldesi R Drugs Aging; 2003; 20(14):1019-34. PubMed ID: 14651442 [TBL] [Abstract][Full Text] [Related]
31. Changing patterns in presentation and management of the Zollinger-Ellison syndrome in Northern Ireland, 1970-1988. Collins JS; Buchanan KD; Kennedy TL; Johnston CF; Ardill JE; Sloan JM; McIlrath EM; Russell C Q J Med; 1991 Mar; 78(287):215-25. PubMed ID: 1675471 [TBL] [Abstract][Full Text] [Related]
33. Three-year oral pantoprazole administration is effective for patients with Zollinger-Ellison syndrome and other hypersecretory conditions. Metz DC; Comer GM; Soffer E; Forsmark CE; Cryer B; Chey W; Pisegna JR Aliment Pharmacol Ther; 2006 Feb; 23(3):437-44. PubMed ID: 16423003 [TBL] [Abstract][Full Text] [Related]
34. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome. Clissold SP; Campoli-Richards DM Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658 [TBL] [Abstract][Full Text] [Related]
35. Medical management of patients with Zollinger-Ellison syndrome who have had previous gastric surgery: a prospective study. Maton PN; Frucht H; Vinayek R; Wank SA; Gardner JD; Jensen RT Gastroenterology; 1988 Feb; 94(2):294-9. PubMed ID: 3335308 [TBL] [Abstract][Full Text] [Related]
36. [Application of proton pump inhibitor to special conditions; Zollinger-Ellison syndrome]. Tani N Nihon Rinsho; 1992 Jan; 50(1):154-9. PubMed ID: 1347327 [TBL] [Abstract][Full Text] [Related]
37. Studies on the interrelation between Zollinger-Ellison syndrome, Helicobacter pylori, and proton pump inhibitor therapy. Weber HC; Venzon DJ; Jensen RT; Metz DC Gastroenterology; 1997 Jan; 112(1):84-91. PubMed ID: 8978346 [TBL] [Abstract][Full Text] [Related]
38. [Long-term efficacy and tolerability of omeprazole in 20 patients with severe Zollinger-Ellison syndrome]. Cadranel JF; Ruszniewski P; Elouaer-Blanc L; Lehy T; Delchier JC; Cadiot G; Florent C; Vatier J; Mignon M Gastroenterol Clin Biol; 1989; 13(8-9):654-62. PubMed ID: 2806801 [TBL] [Abstract][Full Text] [Related]